Charles River Laboratories | CRL - Stock


Charles River Laboratories reported $299.1M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Agilent USD 1.06B 34M Dec/2025
Align Technology USD 228.16M 15.59M Sep/2025
Bio-Rad Laboratories USD 740.7M 42.5M Dec/2025
Bruker USD 1.2B 21.7M Sep/2025
Cardinal Health USD 20.12B 2.56B Dec/2025
Charles River Laboratories USD 299.1M 3.45M Dec/2025
Cigna USD 7.34B 1.71B Dec/2025
CVS Health USD 19.25B 284M Dec/2025
Danaher USD 2.49B 185M Dec/2025
Dentsply International USD 686M 11M Sep/2025
Elevance Health USD 0 0 Dec/2024
Galapagos EUR 22.95M 15.57M Sep/2025
Hologic USD 688.5M 9.1M Dec/2025
Illumina USD 564M 26M Dec/2025
Incyte USD 101.06M 17.61M Dec/2025
Intrexon USD 287K 68K Dec/2022
Laboratory Of America USD 534.7M 13.2M Dec/2025
Lonza CHF 1.68B 163M Dec/2025
McKesson USD 27.07B 933M Dec/2025
Merck EUR 4.47B 45M Jun/2025
Mettler Toledo International USD 387.23M 14.58M Dec/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Quest Diagnostics USD 189M 3M Dec/2025
Revvity USD 379.5M 420K Dec/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
United Therapeutics USD 183.1M 6.6M Dec/2025
UnitedHealth USD 280M 280M Dec/2023
Waters USD 572.37M 570K Dec/2025
West Pharmaceutical Services USD 443.9M 5.9M Dec/2025